Stock & Company Details
Agios Pharmaceuticals Inc $AGIO
Price:
N/A
N/A
60M
$1.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.55
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AGIO technical indicators
Latest Agios Pharmaceuticals Inc (AGIO) indicator readings as of 2026-10-09.
AGIO's 14-day RSI is 41.8, in neutral territory. At $31.81 it is trading 2.0% above its 200-day moving average of $31.18, and below its 50-day average of $33.07. Price sits in the middle of its Bollinger Bands ($31.00 to $34.70). ADX reads 10.8, indicating a range-bound market rather than a trend.
Overview
Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
Finance Bot
Ask your questions
Start by typing a question below.
